H. Lundbeck A/S is to acquire Longboard Pharmaceuticals Inc. in an all-cash deal valuing the epilepsy specialist at $2.6 billion. The agreed price of $60 per share is a 54% premium to the closing ...

Rowley Law PLLC is investigating potential securities law violations by Longboard Pharmaceuticals, Inc. and its board of directors concerning the proposed acquisition of the company by H. Lundbeck A/S ...

Stocks and traders shift into high gear for the final trading hour of the day. Market Domination hosts Julie Hyman and Josh ...

NEW YORK (AP) — Wall Street rolled to more records Monday as U.S. stocks added to their all-time highs. The S&P 500 climbed 0.8% to build on its record set on Friday. It’s coming off its fifth ...

Health-care companies rose amid deal activity and earnings optimism. Shares of Longboard Pharmaceuticals surged after rival H. Lundbeck agreed to buy the biopharmaceutical firm for about $2.6 billion.

Wall Street started the week soaring on Monday, with both the S&P 500 and Dow Jones Industrial Average hitting new records as ...